Support PenkeSupernus Pharmaceuticals Inc - Trending symbols
Latest News of Supernus Pharmaceuticals Inc
| Date | Title | Read |
|---|---|---|
| 2025-06-17 13:34 | Supernus buys Sage Therapeutics for $561 million as Cantor holds rating | Read |
| 2025-06-16 15:14 | Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million | Read |
| 2025-06-16 14:37 | Sage Therapeutics shares soar after supernus acquisition deal | Read |
| 2025-06-16 14:29 | Stocks making the biggest moves premarket: U.S. Steel, Roku, Celsius, Sarepta Therapeutics and more | Read |
| 2025-06-16 13:27 | Supernus to acquire depression drugmaker Sage | Read |
| 2025-06-16 13:00 | Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio | Read |
| 2025-05-28 22:05 | Supernus Announces Paragraph IV ANDA Filings for Qelbree® | Read |
| 2025-05-28 22:05 | Supernus to Participate in the 2025 Jefferies Global Healthcare Conference | Read |
| 2025-05-28 22:05 | Supernus to Participate in the 2025 Jefferies Global Healthcare Conference | Read |
| 2025-05-28 22:05 | Supernus Announces Paragraph IV ANDA Filings for Qelbree® | Read |
Trends
| 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Income before Tax | 243 | 26,059 | 26,302 | 18,641 | 44,943 | -18,561 | 26,382 | -32,213 | -5,831 | |
| Net Income | 124 | 19,792 | 19,916 | 18,581 | 38,497 | -23,169 | 15,328 | -27,155 | -11,827 | |
| Net Income from Continuing Operations | 124 | 19,792 | 19,916 | 18,581 | 38,497 | -23,169 | 15,328 | -27,155 | -11,827 | |
| Net Debt | -52,664 | 19,137 | -33,527 | 12,253 | -21,274 | 9,162 | -12,112 | 18,592 | 6,480 | |
| Accumulated Other Comprehensive Income | -1,206 | 613 | -593 | 59 | -534 | 162 | -372 | 450 | 78 | |
| Operating Income | 148,571 | 25,127 | 173,698 | -87,669 | 86,029 | -18,726 | 67,303 | -72,572 | -5,269 | |
| Total Other Income Expense Net | -1,084 | -3,966 | -5,050 | -7,804 | -12,854 | 6,294 | -6,560 | 14,598 | 8,038 | |
| EBITDA | 170,194 | 39,810 | 210,004 | -89,947 | 120,057 | 29,876 | 149,933 | -155,202 | -5,269 | |
| EBIT | 11,346 | -9,580 | 1,766 | 32,568 | 34,334 | -25,459 | 8,875 | -24,302 | -15,427 | |
| Net Income Applicable to Common Shares | 7,865 | -6,116 | 1,749 | 23,732 | 25,481 | -8,533 | 16,948 | -17,779 | -831 | |
| Net Working Capital | 355,797 | 77,867 | 433,664 | -147,453 | 286,211 | -2,253 | 283,958 | -394,374 | -110,416 | |
| Net Interest Income | -2,285 | -593 | -2,878 | -766 | -3,644 | -403 | -4,047 | 16,803 | 12,756 |
Comments
How you think about this?